Related Experiment Video
Updated: Jul 17, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
The value of percutaneous coronary intervention in aortic valve stenosis with coronary artery disease
Ronny Alcalai1, Nicola Viola, Morris Mosseri
1Heart Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Insights
Percutaneous coronary intervention (PCI) is a safe treatment for coronary artery disease (CAD) in patients with severe aortic stenosis (AS), offering symptom relief and good outcomes for select individuals.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Severe symptomatic aortic stenosis (AS) typically requires aortic valve replacement (AVR).
- Coronary artery disease (CAD) frequently coexists with AS, complicating symptom attribution and treatment planning.
- Percutaneous coronary intervention (PCI) may defer or replace surgical intervention in some patients.
Purpose of the Study:
- To assess the feasibility and outcomes of PCI for CAD in patients with severe AS.
- To identify patient subgroups most likely to benefit from PCI in this complex scenario.
Main Methods:
- Retrospective analysis of 38 patients with severe AS undergoing PCI for CAD (1989-2004).
- Inclusion of demographic, clinical, angiographic, and echocardiographic data.
- Evaluation of PCI complications, symptom improvement, AVR, and mortality during follow-up.
Main Results:
- The study group averaged 71 years old with a mean aortic valve area of 0.84 cm².
- PCI was chosen due to patient preference, high surgical risk, or cardiologist recommendation.
- 92.1% of patients reported symptomatic improvement with no major PCI complications; good functional class and single-vessel disease predicted better long-term survival.
Conclusions:
- PCI is a safe and effective option for managing CAD in patients with severe AS.
- Symptomatic relief is common, and good long-term outcomes are achievable in carefully selected patients.
- PCI should be considered for patients with mild CAD, good functional class, or high surgical risk.
Objectives:
The study determines whether treatment of coronary disease by percutaneous coronary intervention (PCI) in the presence of severe aortic stenosis (AS) is feasible and defines which patients might benefit most.
Background:
Severe symptomatic AS is considered a class I indication for aortic valve replacement (AVR). Many patients with AS have concomitant coronary artery disease (CAD), and the true reason for symptoms is often unclear. It is common practice to combine AVR with coronary artery bypass grafting. However, in some cases PCI alone might improve symptoms and allow surgery to be deferred.
Methods:
We analyzed 38 consecutive patients who underwent PCI for CAD in the presence of significant AS between 1989 and 2004. Data included demographic factors, clinical features, angiographic, and echocardiographic information. Events during follow-up included PCI complications, improvement post-PCI, AVR, and death. Statistical analysis was used to assess the impact of PCI on outcome and survival.
Results:
The mean age of the study group was 71 +/- 9.3 years, and the mean aortic valve area was 0.84 +/- 0.28 (0.4-1.2) cm2. Reasons for choosing PCI over surgery were patients' preference, high surgical risk, and cardiologist recommendation. Thirty-five patients (92.1%) reported symptomatic improvement after PCI, and no major PCI-related complications were recorded. Significant predictors for long-term event-free survival were good functional class (P = .006) and single-vessel coronary disease (P = .017).
Conclusion:
PCI in patients with severe AS and significant CAD is safe, offers relief of symptoms in most cases, and has good long-term outcome in a subset of patients who have mild CAD and good functional class. This therapeutic approach should be considered in such patients and in those with high surgical risk.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
